LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,428.88
+1.38%Forward multiples
Based on analyst estimates
- P/E forward
- 30.41x
- P/E 2026E
- 40.58x
- P/E 2027E
- 28.86x
- P/E 2028E
- 25.15x
- P/S forward
- 13.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 46.26x
- PEG TTM
- 0.89x
- Price / book
- 33.38x
- Price / sales
- 15.55x
- Price / cash flow
- 43.86x
Enterprise value
- Enterprise value
- $1.39T
- EV / sales
- 16.06x
- EV / EBITDA
- 31.03x
- EV / EBIT
- 34.87x
- Market cap
- $1.34T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026